8-K: Nuwellis Announces CEO Retirement and Appoints Interim Replacement

Nestor Jaramillo, Jr. retires as President and CEO of Nuwellis, Inc., with John Erb appointed as Interim President and CEO, effective February 18, 2025.

Summary

• Nuwellis, Inc. announced the retirement of Nestor Jaramillo, Jr. as President and Chief Executive Officer, effective February 18, 2025.
• John L. Erb, the current Chairman of the Board, has been appointed as Interim President and Chief Executive Officer.
• Mr. Jaramillo will receive six months of his base salary, a lump sum payment of $47,723.42 related to a 2024 bonus, and continued health care benefits through August 31, 2025, subject to certain conditions.
• Outstanding stock options that would have vested during the six-month period following Mr. Jaramillo's retirement will be accelerated and vest as of the retirement date.
• Mr. Erb will receive an annual salary of $300,000 as Interim CEO and will continue to serve as Chairman of the Board.
• Nuwellis intends to retain an executive search firm to identify a permanent CEO.

Sentiment

Score: 6

Explanation: The announcement is neutral, detailing a planned leadership transition. While the departure of a CEO can create uncertainty, the appointment of an experienced interim CEO and the search for a permanent replacement suggest a stable outlook.

Positives

• John Erb's extensive experience, including his previous role as CEO of Nuwellis and CHF Solutions, provides stability during the transition.
• The separation agreement with Nestor Jaramillo ensures a smooth transition and continued cooperation.
• The company is actively seeking a permanent CEO, indicating a commitment to long-term leadership.

Negatives

• The departure of the CEO creates uncertainty regarding the company's strategic direction.
• An interim CEO may not be able to implement long-term strategies effectively.
• The company faces the cost and disruption associated with searching for and onboarding a new CEO.

Risks

• The company's ability to execute its commercialization strategy may be affected by the leadership transition.
• The company may face challenges in raising sufficient funds for its operations.
• The company's future performance is subject to risks related to market acceptance of its products, competition, and intellectual property protection.

Future Outlook

Nuwellis intends to retain an executive search firm to identify a permanent CEO and continue executing on its near-term priorities.

Management Comments

• John Erb stated that Nestor Jaramillo played a prominent role in the company's growth and made important strategic contributions.
• John Erb expressed his honor to serve as Interim President and Chief Executive Officer and his commitment to working closely with the management team.

Industry Context

Leadership changes are common in the medical device industry, especially for companies undergoing strategic shifts or seeking to accelerate growth. Nuwellis's focus on commercializing the Aquadex SmartFlow system places importance on finding a CEO with relevant experience in market expansion and product adoption.

Comparison to Industry Standards

• Interim CEO compensation packages in the medical device industry typically include a base salary, benefits, and potential performance-based incentives.
• Companies like Medtronic and Boston Scientific often use executive search firms to identify and recruit top talent for CEO positions.
• Severance agreements for departing CEOs often include salary continuation, bonus payments, and benefits continuation, similar to the terms provided to Mr. Jaramillo.

Management Changes

Stakeholder Impact

• Shareholders may experience short-term uncertainty due to the leadership transition.
• Employees may be affected by changes in strategic direction under new leadership.
• Customers and partners may experience a period of adjustment as the company navigates the transition.

Next Steps

• Nuwellis will retain an executive search firm to identify a permanent CEO.
• John Erb will serve as Interim President and CEO while continuing as Chairman of the Board.
• The company will continue to execute on its near-term priorities.

Key Dates